Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harimoto

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 6, 2014
Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsisT Yoshizumi, K Shirabe, T Ikegami, et al.
Transplantation Proceedings|June 7, 2017
Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation for Primary Sclerosing Cholangitis: Report of a CaseT Motomura, T Yoshizumi, H Wang, et al.
Transplantation Proceedings|December 5, 2017
Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case ReportT Motomura, T Yoshizumi, M Ohira, et al.
Transplantation Proceedings|December 23, 2018
Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse LiverN Harimoto, H Nakagawara, K Shirabe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone?H Uchiyama, K Shirabe, H Nakagawara, et al.
Transplantation Proceedings|December 23, 2018
Real-Time Ultrasound-Guided Thrombectomy for Extensive Portal Vein Thrombosis in Living Donor Liver TransplantationY Soejima, T Yoshizumi, T Ikegami, et al.
Transplantation Proceedings|May 20, 2014
Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosisN Harimoto, T Ikegami, H Nakagawara, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatmentT Hatanaka, S Kakizaki, T Nagashima, et al.
Transplantation Proceedings|April 21, 2015
Thymoglobulin for steroid-resistant immune-mediated graft dysfunction during simeprevir-based antiviral treatment for post-transplantation hepatitis C: case reportK Takeishi, T Ikegami, T Yoshizumi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Correlation between portal vein anatomy and bile duct variation in 407 living liver donorsK Takeishi, K Shirabe, Y Yoshida, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 6, 2014
Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsisT Yoshizumi, K Shirabe, T Ikegami, et al.
Transplantation Proceedings|June 7, 2017
Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation for Primary Sclerosing Cholangitis: Report of a CaseT Motomura, T Yoshizumi, H Wang, et al.
Transplantation Proceedings|December 5, 2017
Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case ReportT Motomura, T Yoshizumi, M Ohira, et al.
Transplantation Proceedings|December 23, 2018
Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse LiverN Harimoto, H Nakagawara, K Shirabe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone?H Uchiyama, K Shirabe, H Nakagawara, et al.
Transplantation Proceedings|December 23, 2018
Real-Time Ultrasound-Guided Thrombectomy for Extensive Portal Vein Thrombosis in Living Donor Liver TransplantationY Soejima, T Yoshizumi, T Ikegami, et al.
Transplantation Proceedings|May 20, 2014
Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosisN Harimoto, T Ikegami, H Nakagawara, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatmentT Hatanaka, S Kakizaki, T Nagashima, et al.
Transplantation Proceedings|April 21, 2015
Thymoglobulin for steroid-resistant immune-mediated graft dysfunction during simeprevir-based antiviral treatment for post-transplantation hepatitis C: case reportK Takeishi, T Ikegami, T Yoshizumi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Correlation between portal vein anatomy and bile duct variation in 407 living liver donorsK Takeishi, K Shirabe, Y Yoshida, et al.
Pageof 3